Compounds > fullerene c60
Page last updated: 2024-09-03

fullerene c60 and Apoplexy

fullerene c60 has been researched along with Apoplexy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ageev, SV; Jakovleva, AA; Kirik, OV; Kolpakova, ME; Korzhevskii, DE; Kukaliia, ON; Maistrenko, DN; Meshcheriakov, AA; Molchanov, OE; Murin, IV; Novikova, TA; Petrov, AV; Poliakova, LS; Semenov, KN; Sharoyko, VV; Vlasov, TD1
Cam, E; Fluri, F; Grünstein, D; Hatz, F; Israel, I; Kleinschnitz, C; Moch, H; Orts-Gil, G; Samnick, S; Schaeren-Wiemers, N; Schäfer, J; Seeberger, P; Ungethuem, U; Zeis, T1

Other Studies

2 other study(ies) available for fullerene c60 and Apoplexy

ArticleYear
C
    Nanomedicine : nanotechnology, biology, and medicine, 2023, Volume: 53

    Topics: Antioxidants; Arginine; Fullerenes; Humans; Ischemia; Ischemic Stroke; Nanostructures; Stroke; Water

2023
Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats.
    Experimental neurology, 2015, Volume: 265

    Topics: Animals; Brain Ischemia; Cerebral Infarction; Fullerenes; Glucosamine; Hypertension; Injections, Intravenous; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke

2015